PFM Health Sciences’s BeyondSpring BYSI Stock Holding History

PFM Health Sciences’s Portfolio BYSI Stock Details BYSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-161,697	Closed	-$2.55M	–	77
2021 Q3	$2.55M	Buy	+161,697	New	+$2.91M	0.07%	81

Other funds holding BYSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFM Health Sciences's BYSI Position: Q4 2021 in Review

PFM Health Sciences sold out of BeyondSpring (BYSI) in Q4 2021, closing a stake of 161,697 shares — an estimated $2.55M sold.

PFM Health Sciences first reported a position in BYSI in Q3 2021 and held it in 1 quarter. The position peaked at $2.55M in Q3 2021. 67 funds tracked by Wall St. Rank hold BYSI as of Q4 2021.

PFM Health Sciences reported no remaining BeyondSpring position as of Q4 2021 after selling out during the quarter.
PFM Health Sciences sold 161,697 BeyondSpring shares in Q4 2021, an estimated $2.55M.
PFM Health Sciences first reported a position in BeyondSpring in Q3 2021 and held it in 1 quarter.
PFM Health Sciences's BeyondSpring position peaked at $2.55M in Q3 2021.
67 funds tracked by Wall St. Rank held BeyondSpring as of Q4 2021.

Based on PFM Health Sciences's 13F filing for Q4 2021, filed 14 Feb 2022.